ZNF562 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.538400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.735800E-01
Normal-vs-Stage2
9.333000E-01
Normal-vs-Stage3
3.812400E-01
Normal-vs-Stage4
3.064000E-01
Stage1-vs-Stage2
5.601400E-01
Stage1-vs-Stage3
7.738200E-02
Stage1-vs-Stage4
2.214400E-01
Stage2-vs-Stage3
3.248200E-01
Stage2-vs-Stage4
1.027420E-01
Stage3-vs-Stage4
5.948300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.306000E-01
Normal-vs-AfricanAmerican
9.105000E-01
Normal-vs-Asian
8.786800E-01
Caucasian-vs-AfricanAmerican
8.102600E-01
Caucasian-vs-Asian
8.793600E-01
AfricanAmerican-vs-Asian
7.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.187200E-01
Normal-vs-Female
9.971600E-01
Male-vs-Female
6.820400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.523400E-01
Normal-vs-Age(41-60Yrs)
7.572200E-01
Normal-vs-Age(61-80Yrs)
8.048400E-01
Normal-vs-Age(81-100Yrs)
5.452600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.146600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.714000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.663440E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.236000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.413410E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.183600E-01
Normal-vs-Daily Drinker
2.524800E-01
Normal-vs-Weekly Drinker
9.205800E-01
Normal-vs-Occasional Drinker
7.071400E-01
Normal-vs-Social Drinker
7.814000E-01
Non Drinker-vs-Daily Drinker
1.829230E-01
Non Drinker-vs-Weekly Drinker
5.395600E-01
Non Drinker-vs-Occasional Drinker
7.810200E-02
Non Drinker-vs-Social Drinker
1.405370E-01
Daily Drinker-vs-Weekly Drinker
1.207160E-01
Daily Drinker-vs-Occasional Drinker
3.956800E-03
Daily Drinker-vs-Social Drinker
1.990340E-02
Weekly Drinker-vs-Occasional Drinker
4.523200E-01
Weekly Drinker-vs-Social Drinker
5.290200E-01
Occasional Drinker-vs-Social Drinker
9.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.203600E-02
Normal-vs-Grade 2
1.525970E-02
Normal-vs-Grade 3
1.276380E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.449600E-01
Grade 1-vs-Grade 3
5.638200E-01
Grade 1-vs-Grade 4
9.203600E-02
Grade 2-vs-Grade 3
6.923800E-01
Grade 2-vs-Grade 4
1.525970E-02
Grade 3-vs-Grade 4
1.276380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.422600E-01
Normal-vs-NonDiabetic
8.929200E-01
Diabetic-vs-NonDiabetic
2.821400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.624400E-01
Normal-vs-NoPancreatitis
8.586800E-01
Pancreatitis-vs-NoPancreatitis
6.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.915400E-01
Normal-vs-N1
9.566800E-01
N0-vs-N1
8.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.734400E-01
Normal-vs-TP53-NonMutant
9.405200E-01
TP53-Mutant-vs-TP53-NonMutant
5.283400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
